Department of Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Nature. 2009 Nov 12;462(7270):182-8. doi: 10.1038/nature08543.
Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the NOTCH transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate NOTCH activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the NOTCH transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.
直接抑制转录因子复合物仍然是配体发现领域的一个核心挑战。一般来说,这些蛋白质缺乏适合小分子高亲和力结合的表面卷曲。在这里,我们报告了设计合成的、可穿透细胞的、稳定的α-螺旋肽,这些肽靶向 NOTCH 反式激活复合物中的一个关键蛋白-蛋白界面。我们证明,烃链订书肽 SAHM1 的直接、高亲和力结合可阻止活性转录复合物的组装。NOTCH 的异常激活直接涉及多种疾病状态的发病机制,包括 T 细胞急性淋巴细胞白血病(T-ALL)。用 SAHM1 处理白血病细胞会导致 NOTCH 激活基因的全基因组抑制。NOTCH 转录程序的直接拮抗作用在培养细胞和 NOTCH1 驱动的 T-ALL 小鼠模型中引起强烈的、NOTCH 特异性的抗增殖作用。